Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CMS Fields Many Suggestions And Criticisms On Proposed VAD Policy

This article was originally published in The Gray Sheet

Executive Summary

Several stakeholders are still pushing CMS to recognize “bridge-to-decision” heart failure patients who may eventually be suitable for a heart transplant but are not so at the time they receive a ventricular assist device.

Advertisement

Related Content

Tug Of War In The LVAD Market
CMS Sticks To Its Original Thinking In Final VAD Coverage Decision
Physicians Want CMS To Rethink Indications For LVADs, Recognize “Bridge-To-Decision” Patients
Medicare Panel Laments Holes In Ventricular Assist Device Evidence Base

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT032386

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel